T1	p 61 107	outpatients with a major depressive disorder .
T2	p 189 228	outpatients with primary depression was
T3	i 33 57	doxepin versus bupropion
T4	i 165 185	bupropion to doxepin
T5	i 319 340	7-day placebo washout
T6	i 417 431	Antidepressant
T7	i 676 683	Doxepin
T8	i 698 707	bupropion
T9	i 775 782	doxepin
T10	i 824 843	bupropion . Doxepin
T11	i 990 999	bupropion
T12	i 1076 1083	doxepin
T13	i 1096 1107	bupropion .
T14	o 251 270	efficacy and safety
T15	o 417 440	Antidepressant response
T16	o 461 616	Hamilton Depression and Anxiety Scales , Clinical Global Severity and Improvement Ratings , and the Zung Self-Rating Depression Scale . Comparable efficacy
T17	o 722 734	sleep factor
T18	o 742 767	Hamilton Depression Scale
T19	o 793 798	sleep
T20	o 863 1001	incidence of anticholinergic side effects , including dry mouth , constipation , sleepiness , and tiredness , in comparison to bupropion .
T21	o 1009 1043	increased appetite and weight gain
T22	o 1060 1072	side effects